Peace of mind for biomolecule analysis

Article

Sponsored Content

Shimadzu has introduced the new “Nexera Bio” solution, a biocompatible Ultra-High Performance Liquid Chromatography (UHPLC) system. It offers the same superior reliability, robustness and expandability as other Nexera series UHPLC systems. It is particularly well suited for analyzing protein-based pharmaceuticals, antibody drugs and other substances developed or manufactured using biotechnologies. The Nexera Bio is compatible with mobile phase solvents containing high concentrations of salts or acids, and has also been designed to inhibit peak tailing caused by adsorption to tubing. The Nexera Bio is equipped with new and advanced product features such as maximum corrosion resistance, low surface activity and minimized sample loss.

 

The new “Nexera Bio” solution, the biocompatible Ultra-High Performance Liquid Chromatography (UHPLC) system of Shimadzu

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Drug Digest: Focusing on Solid Dosage Trends and Demand
Behind the Headlines, episode 7
Related Content